recognized estrogen receptor 1 (ESR1), opioid receptor mu 1 (OPRM1), and hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1) as promising therapeutic targets for psoriasis [17]. This evidence concerns the gene HSD11B1 and psoriasis.